Arisan Therapeutics, Inc.

This study tested two different forms of the experimental drug ARN-75039 in 16 healthy adults to see how the body absorbs each form after a meal. Participants took a single dose of each form one week apart. The goal was to compare the drug levels in the blood, not to treat any di…

This early-stage study tested an experimental oral drug called ARN-75039, being developed to treat Lassa fever, a serious viral illness. The trial involved 94 healthy adults aged 18 to 55 who received either the drug or a placebo to check for side effects and how the drug moves t…